Emerson Electric Co (EMR)

EMR (NYSE:Industrial)
neg -0.20
Today's Range: 62.52 - 63.21 | EMR Avg Daily Volume: 3,325,600
Last Update: 10/30/14 - 1:15 PM EDT
Volume: 1,402,413
YTD Performance: -9.80%
Open: $62.83
Previous Close: $63.30
52 Week Range: $57.76 - $70.66
Oustanding Shares: 697,915,249
Market Cap: 44,233,868,482
6-Month Chart
TheStreet Ratings Grade for EMR
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 5 5
Moderate Buy 1 1 1 1
Hold 9 9 9 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.12 2.12 2.27 2.27
Latest Dividend: 0.43
Latest Dividend Yield: 2.71%
Dividend Ex-Date: 08/13/14
Price Earnings Ratio: 17.85
Price Earnings Comparisons:
EMR Sector Avg. S&P 500
17.85 17.80 27.09
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-4.24% -6.07% 27.60%
Revenue 1.10 0.17 0.05
Net Income 2.10 0.02 0.01
EPS 3.40 -0.03 -0.01
Earnings for EMR:
Revenue 24.67B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (09/14) FY (09/15)
Average Estimate $1.22 $0.73 $3.70 $4.05
Number of Analysts 13 8 15 16
High Estimate $1.25 $0.77 $3.75 $4.28
Low Estimate $1.19 $0.69 $3.65 $3.88
Prior Year $1.18 $0.67 $3.54 $3.70
Growth Rate (Year over Year) 3.65% 9.14% 4.41% 9.71%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Oct 29, 2014 | 6:50 AM EDT
EMR was downgraded from Outperform to Market Perform, Wells Fargo said. Estimates also cut, given the company's new guidance. 
Corporate activism should continue to be a positive for stock prices.
Determining fair value makes buy-sell decisions easier.
Growth estimates suggest a significant upside for the stock.
Banks and industrials are deal-less sectors in a deal-filled world, and that is what's making them suffer.

This Morning's Market Setup Real Money Pro($)

Where it began.
Jul 11, 2014 | 8:28 AM EDT
EMR was upgraded from Hold to Buy, Argus said. $75 price target. Company can continue to deliver consistent growth and buy back stock. ...
Firms that have experienced down years can be much safer bets.
Standing still is no longer an option.
Each of these 'real' American firms is now a buyout candidate because of the ridiculous U.S. tax code.

Columnist Conversations

The Fibocall: Twitter updated from October 28 "All is not lost, though, as the stock is about to enter the bou...
The Fibocall: Amazon updated from October 24 (DAY 1) "Readers of The Fibocall know that we like to examine sto...
Gilead Sciences (GILD) bouncing back strongly after a bit of a sell-off yesterday after earnings report after ...
Carley, I could not disagree more on the value of the CFTC data. The numbers cannot be pooled on a cross-sect...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.